Luminopia

Biotechnology ResearchMassachusetts, United States11-50 Employees

Luminopia is pioneering a new class of treatments for significant neuro-visual disorders. Luminopia is committed to creating digital therapeutics that are both rigorously evaluated for FDA approval and genuinely engaging for patients. As an Innovation Partner of Boston Children’s Hospital, the company is developing its lead product to treat amblyopia, the leading cause of vision loss among children. For more information, visit luminopia.com. 

Please see Luminopia Directions For Use for more information: luminopia.com/dfu

Sign up for free to view info

Email Format Employee directory